June 27, 2023 – Investing Wealth Daily

US FDA declines to approve Regeneron’s higher-dose Eylea, shares tumble

By Khushi Mandowara (Reuters) – U.S. health regulators on Tuesday declined to approve a higher-dose version of Regeneron Pharmaceuticals’ drug…

By Hyunjoo Jin and Trevor Hunnicutt (Reuters) -Tesla’s electric-vehicle charging technology is being put on a fast track to become…

By Nivedita Balu and Fergal Smith TORONTO (Reuters) – Canada’s record pace of interest rate hikes has led to the…

(Reuters) -Thomson Reuters said on Monday it had agreed to acquire Casetext, a legal startup with an artificial intelligence-powered assistant…

By Lucia Mutikani WASHINGTON (Reuters) – U.S. consumer confidence increased in June to the highest level in nearly 1-1/2 years…

(Reuters) – Swedish carmaker Volvo Cars said on Tuesday it had signed an agreement with Tesla to give its electric…

By Jarrett Renshaw (Reuters) -Washington state plans to require electric vehicle charging companies to include Tesla’s plug if they want…